Radiotherapy and tumor immunity

Abstract

Xu Tao, Jing Hongxia. Radiotherapy and tumor immunity[J]. Journal of International Oncology, 2016, 43(11): 855-857.

［1］ Vatner RE, Cooper BT, VanpouilleBox C, et al. Combinations of immunotherapy and radiation in cancer therapy［J］. Front Oncol, 2014, 4: 325. DOI: 10.3389/fonc.2014.00325. ［2］ Golden EB, Formenti SC. Is tumor (R)ejection by the immune system the "5th R" of radiobiology?［J］. Oncoimmunology, 2014, 3(1): e28133. DOI: 10.4161/onci.28133. ［3］ Surace L, Lysenko V, Fontana AO, et al. Complement is a central mediator of radiotherapyinduced tumorspecific immunity and clinical response［J］. Immunity, 2015, 42(4): 767-777. DOI: 10.1016/j.immuni.2015.03.009. ［4］ Golden EB, Apetoh L. Radiotherapy and immunogenic cell death［J］. Semin Radiat Oncol, 2015, 25(1): 1117. DOI: 10.1016/j.semradonc.2014.07.005. ［5］ Gameiro SR, Jammeh ML, Wattenberg MM, et al. Radiationinduced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing［J］. Oncotarget, 2014, 5(2): 403-416. DOI: 10.18632/oncotarget.1719. ［6］ Park B, Yee C, Lee KM. The effect of radiation on the immune response to cancers［J］. Int J Mol Sci, 2014, 15(1): 927943. DOI: 10.3390/ijms15010927. ［7］ Kahn J, Tofilon PJ, Camphausen K. Preclinical models in radiation oncology［J］. Radiat Oncol, 2012, 7: 223. DOI: 10.1186/1748-717X-7-223. ［8］ Hurwitz AA, Watkins SK. Immune suppression in the tumor microenvironment: a role for dendritic cellmediated tolerization of T cells［J］. Cancer Immunol Immunother, 2012, 61(2): 289-293. DOI: 10.1007/s00262-011-1181-5. ［9］ Haikerwal SJ, Hagekyriakou J, Macmanus M, et al. Building immunity to cancer with radiation therapy［J］. Cancer Lett, 2015, 368(2): 198-208. DOI: 10.1016/j.canlet.2015.01.009. ［10］ Shahabi V, Postow MA, Tuck D, et al. Immunepriming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy［J］. Am J Clin Oncol, 2015, 38(1): 90-97. DOI: 10.1097/COC.0b013e3182868ec8. ［11］ Verbrugge I, Hagekyriakou J, Sharp LL, et al. Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies［J］. Cancer Res, 2012, 72(13): 3163-3174. DOI: 10.1158/00085472.CAN120210. ［12］ Roses RE, Datta J, Czerniecki BJ. Radiation as immunomodulator: implications for dendritic cellbased immunotherapy［J］. Radiat Res, 2014, 182(2): 211-218. DOI: 10.1667/RR13495.1. ［13］ Simpson TR, Li F, MontalvoOrtiz W, et al. Fcdependent depletion of tumorinfiltrating regulatory T cells codefines the efficacy of antiCTLA4 therapy against melanoma［J］. J Exp Med, 2013, 210(9): 16951710. DOI: 10.1084/jem.20130579. ［14］ Wu L, Wu MO, De La Maza L, et al. Targeting the inhibitory receptor CTLA4 on T cells increased abscopal effects in murine mesothelioma model［J］. Oncotarget, 2015, 6(14): 1246812480. DOI: 10.18632/oncotarget.3487. ［15］ Ruocco MG, Pilones KA, Kawashima N, et al. Suppressing T cell motility induced by antiCTLA4 monotherapy improves antitumor effects［J］. J Clin Invest, 2012, 122(10): 37183730. DOI: 10.1172/JCI61931. ［16］ Finkelstein SE, Iclozan C, Bui MM, et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of highrisk soft tissue sarcoma patients［J］. Int J Radiat Oncol Biol Phys, 2012, 82(2): 924-932. DOI: 10.1016/j.ijrobp.2010.12.068. ［17］ Slovin SF, Higano CS, Hamid O, et al. Ipilimumab (IPI) in metastatic castrateresistant prostate cancer (mCRPC): results from an openlabel, multicenter phase Ⅰ/Ⅱ study［J］. Ann Oncol, 2013, 24(7): 1813-1821. DOI: 10.1093/annonc/mdt107. ［18］ Schoenfeld JD, Mahadevan A, Floyd SR, et al. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review［J］. J Immunother Cancer, 2015, 3: 50. DOI: 10.1186/s40425-015-0095-8. ［19］ Kamrava M, Kesarwala AH, Madan RA, et al. Longterm followup of prostate cancer patients treated with vaccine and definitive radiation therapy［J］. Prostate Cancer Prostatic Dis, 2012, 15(3): 289-295. DOI: 10.1038/pcan.2012.7. ［20］ Gandhi SJ, Minn AJ, Vonderheide RH, et al. Awakening the immune system with radiation: optimal dose and fractionation［J］. Cancer Lett, 2015, 368(2): 185-190. DOI: 10.1016/j.canlet.2015.03.024. ［21］ Bloy N, Pol J, Manic G, et al. Trial watch: radioimmunotherapy for oncological indications［J］. Oncoimmunology, 2014, 3(9): e954929. DOI: 10.4161/21624011.2014.954929. ［22］ Schaue D, Ratikan JA, Iwamoto KS, et al. Maximizing tumor immunity with fractionated radiation［J］. Int J Radiat Oncol Biol Phys, 2012, 83(4): 1306-1310. DOI: 10.1016/j.ijrobp.2011.09.049.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[5]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[6]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[7]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[8]	Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488.
[9]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[10]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[11]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）[J]. Journal of International Oncology, 2023, 50(4): 193-201.
[12]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230.
[13]	Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.
[14]	Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases[J]. Journal of International Oncology, 2023, 50(3): 138-143.
[15]	Huang Huayu, Gong Hongyun, Song Qibin.Influencing factors of pneumonitis in the period of thoracic radiotherapy combined with immunotherapy[J]. Journal of International Oncology, 2023, 50(2): 102-106.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments